Skip to main content
Non Traumatic Spinal Cord InjuryDevice

What this study is

Simplified from ClinicalTrials.gov

Testing sticky skin pads over the spine that give electrical stimulation (transcutaneous spinal stimulation) to improve arm and hand function in veterans 18 or older with subacute non-traumatic spinal cord injury who are in hospital rehab. It is compared with functional electrical stimulation, which places the pads over the arm muscles.

Read the original summary from ClinicalTrials.gov

Cervical spinal cord injuries (SCI) are the most common form of spinal cord injuries within the veteran population. Losing arm function is a major concern with these injuries. Doctors often use a treatment called functional electrical stimulation (FES) during rehab sessions targeted at improving arm and hand function. For FES, clinicians places sticky pads on the skin over the muscles that need to move. A newer treatment, called transcutaneous spinal stimulation (TSS), places the pads on the skin over the spine instead. This study compares the two treatments in veterans with non-traumatic spinal cord injuries while they are in the hospital's rehab program. The main goal is to see how well each treatment improves arm and hand function, which is measured with the Capabilities of Upper Extremity Test. If TSS works well, it could help veterans regain more arm and hand function which may result in increased independence.

What's being tested

  • RTI Xcite

    Intervention · DEVICE

    Functional electrical stimulation

  • ExaStim

    Intervention · DEVICE

    Transcutaneous spinal stimulation

Study details

Official title
Comparison of Traditional Functional Electrical Stimulation to Transcutaneous Stimulation on Upper Extremity Outcomes in Patients With Subacute Spinal Cord Injury
Sponsor
Center for Veterans Research and Education
Conditions
Non Traumatic Spinal Cord Injury · Sub-Acute Rehabilitation · Spinal Cord Injury Cervical · Electric Stimulation Therapy · Upper Extremity · Recovery of Function
Enrolling
20 people
Starts
2026-06-18
Est. completion
2030-06-01
Design
Single-blind, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗